# Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

> **NCT03125239** · PHASE1 · COMPLETED · sponsor: **Jacqueline Garcia, MD** · enrollment: 16 (actual)

## Conditions studied

- Relapsed Adult Acute Myeloid Leukemia
- Refractory Adult Acute Myeloid Leukemia

## Interventions

- **DRUG:** Merestinib
- **DRUG:** LY2874455

## Key facts

- **NCT ID:** NCT03125239
- **Lead sponsor:** Jacqueline Garcia, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-10
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03125239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03125239, "Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03125239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*